Home
Clinical Resources Search
PQI: Inavolisib (Itovebi™) Patient Management

Inavolisib (Itovebi™) Patient Management

Last Updated: March 4, 2025

By: Heather Moore, PharmD, BCOP, CPP

About this PQI

This document will provide awareness of the PI3K inhibitor, inavolisib, for patients receiving treatment for hormone receptor (HR)-positive, HER2-negative, advanced/metastatic breast cancer and will discuss counseling, monitoring parameters, and patient management strategies to optimize adherence and improve patient outcomes.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Breast Cancer Inavolisib

PQI

PQI: HER2 Immunohistochemistry Testing in Metastatic Breast Cancer: Guiding Treatment Decisions and the Role of Sacituzumab Govitecan

Last Updated: 02/04/2026

PQI

PQI in Action: Nirogacestat (Ogsiveo) use in Management of Adults with Progressing Desmoid Tumors (or fibromatosis or aggressive fibromatosis)

Last Updated: 10/04/2025

PQI Podcast

Frequently Searched

Supported by

Inavolisib (Itovebi™) Patient Management

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: HER2 Immunohistochemistry Testing in Metastatic Breast Cancer: Guiding Treatment Decisions and the Role of Sacituzumab Govitecan

PQI: Ivosidenib (Tibsovo) and Management of IDH1 Mutant Acute Myeloid Leukemia

PQI: Datopotamab deruxtecan (Datroway): Prophylaxis and Management of Adverse Events

PQI: Streamlining Enrollment in the Medicare Prescription Payment Plan (MPPP)

PQI in Action: Darolutamide (Nubeqa)

PQI in Action: Zolbetuximab (Vyloy) for Gastroesophageal Cancers

PQI in Action: Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

PQI in Action: Nirogacestat (Ogsiveo) use in Management of Adults with Progressing Desmoid Tumors (or fibromatosis or aggressive fibromatosis)

S9 Bonus Episode: From Patient to MIP Advocate

S9 E15: Theranostics: The New Era of Targeted Imaging & Therapy

S9 E14: Immunotherapy and the MyMelanoma Project

S9 E13: A Season of Gratitude

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bi-Specific

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Doxorubicin

Toremifene

Trastuzumab Deruxtecan and Pertuzumab

Fulvestrant

Treatment Support Kit: Inavolisib

Doxorubicin

Irinotecan

Azacitidine and Venetoclax

Toremifene